We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+35.19%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$336M
AUM Growth
+$28.4M
(+9.2%)
Cap. Flow
-$47.2M
Cap. Flow
% of AUM
-14.05%
Top 10 Holdings %
Top 10 Hldgs %
56.86%
Holding
90
New
10
Increased
16
Reduced
26
Closed
16
Top Buys
| 1 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$4.4M |
| 2 |
FLNA
Filana Therapeutics
FLNA
|
+$4.02M |
| 3 |
VERO
Venus Concept
VERO
|
+$3.39M |
| 4 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$2.94M |
| 5 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
+$2.73M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$22.2M |
| 2 |
Arcturus Therapeutics
ARCT
|
+$9.85M |
| 3 |
Fate Therapeutics
FATE
|
+$6.46M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$2.89M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
+$2.76M |
Sector Composition
| 1 | Healthcare | 89.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$161M
| $69.6M | 20.72% |
13,680,554
| – | – |
|
|
2
Fate Therapeutics
FATE
$350M
| $30.4M | 9.05% |
334,360
-104,100
| -24% | -$6.46M |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $23.2M | 6.9% |
206,911
-26,178
| -11% | -$2.76M |
|
|
SAGE
4
DELISTED
Sage Therapeutics
SAGE
| $15.7M | 4.67% |
181,306
+23,000
| +15% | +$1.7M |
|
|
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $12.9M | 3.85% |
587,756
+133,520
| +29% | +$2.94M |
|
6
Neurocrine Biosciences
NBIX
$17.2B
| $8.84M | 2.63% |
92,208
+2,000
| +2% | +$193K |
|
|
LKFT
7
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $7.96M | 2.37% |
80,375
+36,000
| +81% | +$4.4M |
|
8
DexCom
DXCM
$28.5B
| $7.82M | 2.33% |
84,552
| – | – |
|
9
AtriCure
ATRC
$1.75B
| $7.42M | 2.21% |
133,229
| – | – |
|
10
iShares Biotechnology ETF
IBB
$9.22B
| $7.18M | 2.14% |
47,400
-8,500
| -15% | -$1.21M |
|
|
BHVN
11
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.04M | 2.09% |
82,100
-2,500
| -3% | -$212K |
|
|
CSII
12
DELISTED
Cardiovascular Systems, Inc.
CSII
| $6.62M | 1.97% |
151,200
| – | – |
|
|
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.9M | 1.76% |
76,815
+1,000
| +1% | +$75K |
|
14
Xenon Pharmaceuticals
XENE
$6.54B
| $5.33M | 1.59% |
346,535
| – | – |
|
15
ProQR Therapeutics
PRQR
$243M
| $5.2M | 1.55% |
1,237,400
| – | – |
|
|
AFMD
16
DELISTED
Affimed
AFMD
| $5.09M | 1.51% |
87,436
-4,992
| -5% | -$235K |
|
17
Neuronetics
STIM
$132M
| $4.93M | 1.47% |
443,717
-52,055
| -10% | -$391K |
|
18
IDEAYA Biosciences
IDYA
$3.54B
| $4.64M | 1.38% |
331,661
| – | – |
|
|
TBIO
19
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $4.15M | 1.24% |
225,393
+34,463
| +18% | +$617K |
|
20
Accuray
ARAY
$32.6M
| $4.06M | 1.21% |
974,400
-99,900
| -9% | -$367K |
|
|
TVRD
21
Tvardi Therapeutics
TVRD
$28.9M
| $3.96M | 1.18% |
7,262
+390
| +6% | +$204K |
|
|
AERI
22
DELISTED
Aerie Pharmaceuticals
AERI
| $3.9M | 1.16% |
288,440
+4,000
| +1% | +$48.3K |
|
23
Ascendis Pharma A/S
ASND
$17.5B
| $3.88M | 1.15% |
23,237
-6,000
| -21% | -$992K |
|
|
AGTC
24
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.69M | 1.1% |
903,429
-191,710
| -18% | -$942K |
|
|
LMNX
25
DELISTED
Luminex Corp
LMNX
| $3.56M | 1.06% |
154,091
| – | – |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML